References
1 Deveci B et al. Evaluation of the Patients with Hematological
Malignancies along with Synchronous or Metachronous Solid Tumors. Int J
Hematol. 2021;4(31):214–20.
2 Breccia M et al. Cutaneous pleomorphic T-cell lymphoma coexisting with
myelodysplastic syndrome transforming into acute myeloid leukemia:
Successful treatment with a fludarabine-containing regimen. Eur J
Haematol. 2002 Apr;68(1):1–3.
3 Huang H-H et al. Co-existent de novo myelodysplastic syndrome and
T-cell Non-Hodgkin lymphoma: A common origin or not? J Int Med Res. 2009
Feb;37(1):270–6.
4 Anzai T et al. Myelodysplastic syndrome associated with immunoblastic
lymphadenopathy-like T-cell lymphoma: Simultaneous clinical improvement
with chemotherapy. Jpn J Clin Oncol. 1994 Apr;24(2):106–10.
5 Brudno J et al. Discordant bone marrow involvement in non-Hodgkin
Lymphoma. Blood. 2016 Feb;127(8):965–70.
6 Kotchetkov R et al. Synchronous dual hematological malignancies: New
or underreported entity? Hematol. 2018 Jun;23(9):596–9.
7 Zimelman AP. Thrombocytosis in multiple myeloma. Ann Intern Med.
1973;78(6):970–1.
8 Nestler JE. Immunoglobulin D multiple myeloma with thrombocytosis. Ann
Intern Med. 1981 Mar;94(3):412.
9 Ghosh P. Essential Thrombocythaemia and Bence Jones Myeloma. Br Med J.
1984;289:228.
10 Kuroda J et al. JAK2V617F-positive essential thrombocythemia and
multiple myeloma with IGH/CCND1 gene translocation coexist, but
originate from separate clones. Acta Haematol. 2008 Jan;120(3):177–81.
11 Holtan SG, Hoyer JD, Buadi FK. Multiple myeloma with concomitant
jak2-positive essential thrombocythemia post-successful autologous
peripheral blood hematopoietic stem cell transplant. Bone Marrow
Transplant. 2010 Apr;46(4):615.
12 Naeem A et al. Thrombocytosis as an initial presentation of plasma
cell neoplasm: A case report. Cureus. 2019 Mar;11(3):e4268.
13 Selroos O, Assendelft A. Thrombocythaemia and multiple myeloma. Acta
Med Scand. 1977;201(3):243–7.
14 Prósper F et al. Coexistence of essential thrombocythemia and
multiple myeloma. Annals of Hematol. 1992 Aug;65(2):103–5.
15 Kelsey PR, Patel K. Essential thrombocythaemia followed by multiple
myeloma in the same patient. Clin Lab Haematol. 1995 Jan;17(4):349–51.
16 Arlen PM, Goldkland GA. Multiple myeloma after treatment of essential
thrombocythemia. South Med J. 1995 Jan;88(1):79–81.
17 Cobo F et al. Multiple myeloma following essential thrombocythemia.
Leuk Lymphoma. 1995 Dec;20(1-2):177–9.
18 Majhail N, Lichtin AE. Rare coexistence of multiple myeloma with
essential thrombocythemia: report of two cases. Haematologica. 2003
Apr;88(4)e34-5.
19 Eskazan AE et al. Essential thrombocythemia and multiple myeloma: Two
rare diseases in one patient. Clin Lymphoma Myeloma Leuk. 2011
Oct;11(5):442–5.
20 Youssef YB et al. Multiple myeloma following essential
thrombocythemia. Ann Biol Clin. 2013;71(4):457–60.
21 Leković D et al. The emergence of non-secretory multiple myeloma
during the non-cytotoxic treatment of essential thrombocythemia: A case
report. J Med Case Rep. 2013 Sep;7(1):224.
22 Badelita S et al. The simultaneous occurrence of multiple myeloma and
JAK2 positive myeloproliferative neoplasms - Report on two cases. J Med
Life. 2015 Mar;8(1):55–61.
23 Terzi H et al. The Emergence of Multiple Myeloma in a Patient with
Essential Thrombocythemia: A Case Report. J Hematol Blood Disord. 2015
Aug;1(1):101.
24 Loscocco GG et al. Lenalidomide: A double-edged sword for concomitant
multiple myeloma and post‐essential thrombocythemia myelofibrosis. Am J
Hematol. 2021 Mar;96(6):749–54.
25 Thomas A et al. Second malignancies after multiple myeloma: From
1960s to 2010s. Blood. 2012 Mar;119(12):2731–7.
26 Kaser A et al. Interleukin-6 stimulates thrombopoiesis through
thrombopoietin: Role in inflammatory thrombocytosis. Blood. 2001
Nov;98(9):2720–5.
27 Howell DA et al. Time-to-diagnosis and symptoms of myeloma, lymphomas
and Leukaemias: A report from the Haematological Malignancy Research
Network. BMC Blood Disord. 2013 Oct;13(1)1-9.